LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$106.20
2.34 (2.25%)
▲
5d:
+1.61%
30d:
+10.52%
90d:
+38.95%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LNTH trades at premium valuation expecting 8.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: LNTH trades at premium valuation expecting 8.4% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$145.30
Based on 12.0% avg growth
INTRINSIC VALUE TODAY
$90.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $106.20, which is considered extended relative to its 30-day fair value range of $94.91 to $102.44. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.6) compared to its historical average (13.0). At these levels, the market is pricing in 8.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $107.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is approaching resistance at $107.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$94.91 -
$102.44
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.2%
Protect Your Profits
Holding LNTH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($105.23)
- NEUTRAL: Trading at premium valuation - market expects 8.4% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$94.91 -
$102.44
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$97.99
Resistance Level
$107.99
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.60
Wall Street Target
$105.23
(-0.9%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
76.5%
Profit Margin
18.1%
Valuation Premium vs History
+8.4% premium
PE vs Historical
16.6 vs 13.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$115.12
(+8%)
2-Year Target
$124.79
(+18%)
3-Year Target
$135.27
(+27%)
3-Yr Target (if PE normalizes)
(PE: 17→13)
PE COMPRESSION
$105.92
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 19.9%)
$240.35
(+126%)
Base:
(SPY PE: 16.6, Growth: 19.9%)
$183.22
(+73%)
Bear:
(PE: 13.0, Growth: 19.9%)
$143.46
(+35%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 24.89 | Current EPS (TTM): $4.19
Bull Case
$175.16
(+65%)
Analyst growth 52.7%, PE expands to 27.4
Base Case
$159.24
(+50%)
Market implied 52.7%, PE stable at 24.9
Bear Case
$70.93
(-33%)
Severe decline -20.0%, PE contracts to 21.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 6:54 AM ET
Data refreshes hourly during market hours. Next update: 7:54 AM
Data refreshes hourly during market hours. Next update: 7:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 57 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 61 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
